๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

New drug development for pediatric oncology

โœ Scribed by Steven Weitman; Lisa Carlson; Charles B. Pratt

Publisher
Springer US
Year
1996
Tongue
English
Weight
838 KB
Volume
14
Category
Article
ISSN
0167-6997

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

MR in oncology drug development
MR in oncology drug development
โœ Susan M. Galbraith ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 333 KB
New features toMedical and Pediatric Onc
New features toMedical and Pediatric Oncology
โœ D'Angio, Giulio J. ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 8 KB ๐Ÿ‘ 2 views

This issue of Medical and Pediatric Oncology contains the first of a set of feature articles that will appear from time to time in its pages. These will include a series to be entitled ''Topical Topics'' that will provide readers with succinct reviews of recent advances in laboratory, clinical, and

New microtubular agents in pediatric onc
New microtubular agents in pediatric oncology
โœ Nita L. Seibel; Gregory H. Reaman ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› Springer US ๐ŸŒ English โš– 588 KB

The taxanes are a new group of anticancer agents with a novel mechanism of action. They promote microtubule assembly and stabilize the microtubules. Paclitaxel (Taxol), the first agent in this group in clinical trials was isolated from the Pacific yew, Taxus brevifolia in 1971. Both in preclinical a